GlassScriptPhysician profile
Venkatesh Ravi
NPI 1821438227
$31,449.77
in general payments reported to CMS, 2019-2025
32 companies · $1,088 in 2025
The $1,088 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $15K · 2021: $3,022 · 2022: $685 · 2023: $236 · 2024: $292 · 2025: $1,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299 · Travel and Lodging: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.21 |
| Travel and Lodging | $318.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,501.99 | 2019-2025 | General - Therapies, Watchman Flx |
| Medtronic Vascular, INC. | $11,029.87 | 2019-2020 | |
| Biotronik INC. | $2,879.43 | 2019-2021 | |
| Abbott Laboratories | $1,696.97 | 2020-2025 | Aveir |
| Medtronic, INC. | $1,012.49 | 2021-2024 | Flexcath Advance, Pulseselect, Arctic Front Advance |
| Biosense Webster, INC. | $777.19 | 2020-2025 | Carto 3, Qdot Micro Catheter, Soundstar |
| Baylis Medical Company INC | $241.57 | 2019 | |
| Amgen INC. | $185.68 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $171.49 | 2021-2022 | |
| Medical Device Business Services, INC. | $129.00 | 2020 | |
| Cardiovascular Systems INC. | $102.89 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.84 | 2021-2022 | |
| Pfizer INC. | $72.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $61.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.89 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $46.48 | 2021-2022 | |
| Abiomed | $44.12 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $41.80 | 2024 | Rhythm Express |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| Sanofi-Aventis U.S. LLC | $36.63 | 2022 | |
| Philips North America LLC | $33.69 | 2022-2024 | (Ck4) Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $32.24 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $22.53 | 2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $20.13 | 2022 | |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $18.22 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Actelion Pharmaceuticals US, INC. | $17.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.53 | 2022 | |
| Novo Nordisk INC | $15.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.27 | 2021 | |
| Chiesi USA, INC. | $14.10 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkatesh Ravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.